Niramay Clinics

Patient Answers · Weight and obesity

When does a doctor use weight-loss medicines?

Medically reviewed by Dr. Ajay V. Kaduskar · Last reviewed 15 November 2026

Published · 5 min read

Who this page is for

How weight-loss medicines work, who may and may not be suitable, side effects, results in trials, the 2026 generics in India and how supervised treatment works in Nagpur.

The short answer

Weight-loss medicines, mainly GLP-1 receptor agonists and dual GIP and GLP-1 agonists, are prescription medicines in India. They should be started only after a doctor's assessment and continued with monitoring. At Niramay Clinics, Dhantoli, Nagpur, Dr. Ajay V. Kaduskar, a SCOPE certified obesity management specialist, assesses suitability and supervises treatment with laboratory tests, body composition checks and nutrition support.

Weight-loss medicines are prescription medicines that reduce appetite and help the body handle sugar, used alongside diet and activity for people with obesity or with weight-related illness. In India they must be prescribed by a registered doctor, and they are most effective and safest with regular monitoring.

What are weight-loss medicines and how do they work?

Most modern weight-loss medicines copy gut hormones that the body releases after a meal.

Medicine groupHow it worksHow it is taken
GLP-1 receptor agonistsReduce hunger, make you feel full sooner, slow stomach emptying, and help insulin release when sugar is highWeekly or daily injection; one is available as a tablet
Dual GIP and GLP-1 agonistsAct on two gut hormones for a stronger effect on appetite and sugarWeekly injection
Older medicinesReduce fat absorption from food, or act on appetite in other waysTablets; usually smaller effect

Medicines are prescribed only if clinically appropriate after assessment. They are added to diet and activity, not used instead of them.

Who may be suitable for weight-loss medicines?

They are generally considered for adults whose weight is in the obesity range, or who are overweight with weight-related conditions such as type 2 diabetes, high blood pressure, fatty liver or sleep apnoea, when diet and activity have not been enough. For Asian Indians, obesity starts at a lower BMI than in Western countries. The doctor decides, weighing expected benefit against risk.

Who should not take them?

  • Pregnancy, planning a pregnancy, or breastfeeding.
  • A past attack of pancreatitis, or gallbladder disease, without specialist advice.
  • A personal or family history of medullary thyroid cancer or the MEN2 syndrome (for GLP-1 based medicines).
  • An eating disorder.
  • People under 18, except in specialist cases.

Are weight-loss medicines safe?

They are generally safe when prescribed and monitored, but they do have side effects. The common ones are nausea, reduced appetite, fullness, vomiting, constipation or loose motions, especially at the start or after a dose increase. Most settle with slow dose increases, smaller meals and enough water. Rare but serious problems include pancreatitis, gallstones and dehydration that strains the kidneys.

How much weight do people lose?

Results vary from person to person. In the STEP 1 trial (2021), adults with obesity on a weekly GLP-1 receptor agonist lost on average about 15% of body weight over 68 weeks, compared with about 2% on placebo. In the SURMOUNT-1 trial (2022), the highest dose of a weekly dual GIP and GLP-1 agonist led to an average loss of about 21% over 72 weeks. Everyone in these trials also received lifestyle advice. These are averages, not a promise for any individual.

What happens when you stop?

Many people regain weight after stopping. In the STEP 1 extension, people regained about two-thirds of the weight they had lost within a year of stopping. That is why a plan for diet, protein, strength exercise and follow-up matters from the first day, so that more of the benefit lasts. Fast weight loss can also reduce muscle, so tracking fat and muscle on body composition is part of supervised care.

Generic GLP-1 medicines in India in 2026: what changed?

Patents on a widely used GLP-1 medicine expired in India in March 2026, and several Indian companies launched lower-cost generic versions. They are still prescription-only medicines. Counterfeit "weight-loss injections" are being sold online and through informal channels. Buy only from a licensed pharmacy against a doctor's prescription, and never inject a product you cannot trace.

Medicines or surgery: which is right for you?

For most people, medicines with diet and activity come first. Weight-loss surgery may be discussed for severe obesity with serious related conditions when other treatment has not worked. Surgery is not done at Niramay Clinics; patients are referred when appropriate. Your doctor will talk through the trade-offs.

Questions to ask your doctor before starting

  • Is a medicine right for me now, or should I try a structured diet and activity plan first?
  • Which side effects should I expect in the first weeks, and what should I do about them?
  • Do any of my other medicines, such as diabetes tablets or insulin, need to be reduced?
  • How will we protect my muscle while I lose weight?
  • How long might I take it, and what is the plan when we stop?
  • What will the monthly cost be, so I can plan for it?

How supervised treatment works at Niramay Clinics

  1. Assessment: history, weight, waist, blood pressure and your goals.
  2. Tests before starting: body composition, blood sugar, and kidney and liver function.
  3. Decision: whether a medicine suits you, or whether diet and activity alone are the better first step.
  4. Start low, increase slowly: gradual dose increases to limit side effects.
  5. Follow-up: side effects, adjustment of other medicines such as diabetes or BP tablets, and regular body composition checks.
  6. Nutrition support: protein-rich, familiar meals with the clinic's nutrition team; see nutrition counselling.

If you also have diabetes, read weight-loss medicines when you also have diabetes. For the wider plan, see obesity treatment in Nagpur.

Key points

  • Weight-loss medicines are prescription medicines that work with diet and activity.
  • They suit some adults with obesity or weight-related illness, after a doctor's assessment.
  • Side effects are mostly digestive; severe stomach pain or repeated vomiting needs urgent care.
  • Weight often returns after stopping, so long-term habits and follow-up matter.

These medicines can help, but they are not a shortcut and they need supervision. To find out whether a medicine suits you, book an assessment with Dr. Ajay V. Kaduskar at Niramay Clinics, Dhantoli: call or WhatsApp 84591 41584.

Medical disclaimer: This page is general information. Do not start, stop or change any weight-loss medicine without a doctor's assessment.

Frequently asked questions

In Hindi and Marathi

हिंदी

हिंदी में: डॉक्टर की निगरानी में वज़न घटाने की दवाएं

वज़न घटाने की दवाएं डॉक्टर के पर्चे पर ही मिलती हैं और जांच के बाद ही शुरू करनी चाहिए। ऑनलाइन बिना पर्चे के इंजेक्शन न खरीदें। निरामय क्लिनिक्स, धंतोली में डॉ. अजय वी. कडुस्कर जांच, बॉडी कंपोज़िशन और डाइट सलाह के साथ इलाज की निगरानी करते हैं।

मराठी

मराठीत: डॉक्टरांच्या देखरेखीखाली वजन कमी करण्याची औषधे

वजन कमी करणारी औषधे फक्त डॉक्टरांच्या चिठ्ठीवरच घ्यावीत. तपासणीनंतरच सुरुवात करावी आणि नियमित पाठपुरावा करावा. निरामय क्लिनिक्स, धंतोली: 84591 41584.

Questions this page answers

Care at Niramay Clinics

From our Health Library

Sources

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989 to 1002.
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387(3):205 to 216.
  3. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553 to 1564.
  4. American Diabetes Association. Standards of Care in Diabetes 2026: obesity and weight management for the prevention and treatment of diabetes. Diabetes Care. 2026;49(Suppl 1).
  5. Business Today and Medical Dialogues reports on generic GLP-1 launches in India after patent expiry, March 2026.
  6. niramayclinics.com: Weight management medicines, Obesity and Body composition pages, for all clinic facts.

Ready to talk to a specialist?

Call 84591 41584, message us on WhatsApp, or use the appointment form. Please bring your previous reports and a list of the medicines you take.